Biotechnology News

May 3, 2012

PHILADELPHIA--(BUSINESS WIRE)--Integral Molecular Announces Patent Allowance for its Membrane Protein Lipoparticle Technology

May 3, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will be presenting at the Deutsche Bank 37th Annual Health Care Conference on Monday, May 7 at 8:40 am (ET) in Boston.

May 3, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB:CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is thrilled to welcome Dr. Ivan Goldsmith of Trimcare in Las Vegas, Nevada,...

May 3, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Lake Region Medical to Showcase Strategic Technology Developments at the Heart Rhythm 2012 (HRS) Conference in Boston, MA, May 9-12

May 3, 2012

LONDON--(BUSINESS WIRE)--Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that the first UK patients participating in the Company’s multi-centre trial have been...

May 3, 2012

REUTLINGEN, Germany & HONG KONG--(BUSINESS WIRE)--Retina Implant AG (“Retina Implant”), a leading developer of subretinal implants for the visually impaired, today announced that the first patient in China to be implanted with its microchip...

May 3, 2012

TRENTO, Italy--(BUSINESS WIRE)--Installation of an IBA proton beam system is underway at ATreP, Italy's first proton therapy center for cancer treatments.

May 3, 2012

PHILADELPHIA--(BUSINESS WIRE)--Zydus Pharmaceuticals Selects Revitas Flex Platform to Support Growth Model

May 3, 2012

BERLIN--(BUSINESS WIRE)--BIOTRONIK Gives ICD Patients in Asia Pacific First-Ever Access to MR Scans. BIOTRONIK announced the first implantation of the new Lumax 740 ICD.

May 3, 2012

EVERETT, Wash.--(BUSINESS WIRE)--SNBL USA is pleased to announce it has received a response from the U.S. Food and Drug Administration (FDA) regarding the FDA’s September 2011 follow-up and general surveillance inspections.

May 3, 2012

BARNWELL, S.C.--(BUSINESS WIRE)--Barnwell County Hospital announced it has partnered with Radisphere, the national radiology group that is defining quality standards in radiology. Radisphere will work closely with BCH medical staff.

May 3, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Biotechnology company FibroGen decides to expand ongoing Phase 2 study of investigational antifibrotic therapy, FG-3019, in patients with idiopathic pulmonary fibrosis (IPF).

May 3, 2012

TAMPA, Fla. & MINNEAPOLIS--(BUSINESS WIRE)--Biovest reported that new data from the BiovaxID Phase II mantle cell lymphoma clinical trial conducted by the NCI will be presented at the 2012 American Society of Clinical Oncology Annual Meeting...

May 3, 2012

VÄSTRA FRÖLUNDA, Sweden--(BUSINESS WIRE)--Regulatory News: Net revenue amounted to SEK 6.8 million (5.4), an increase of 27 percentage points. The net loss totaled SEK 2.3 million (3.9).   Earnings per stock unit amounted to SEK -0.01 (-0.03)....

May 3, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Metabolix announced the promotion of Max Senechal to Vice President, Biobased Chemicals and his appointment to the executive management team.

May 3, 2012

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Mass spectrometry industry leader, AB SCIEX, uses Facebook, YouTube and Twitter to connect with scientists on mobile lab tour

May 3, 2012

NEWARK, Calif.--(BUSINESS WIRE)--Oraya Therapeutics, Inc.'s INTREPID clinical trial of radiation therapy has met its primary endpoint of reduction in anti-VEGF injections for patients with wet AMD.

May 3, 2012

BOSTON--(BUSINESS WIRE)--The Belfer Institute for Applied Cancer Science at Dana-Farber Cancer Institute today announced that the Institute will co-chair and present at the upcoming Molecular Targeted Therapies: Mechanisms of Resistance, an...

May 3, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (NASDAQ: CLDX) today reported financial results for the first quarter ended March 31, 2012. Celldex reported a net loss of $13.5 million, or $0.27 per share, for the first quarter of...

May 3, 2012

LANCASTER, Calf.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, announced today the release of Version 3.0 of...

May 3, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--CorMedix Inc. (“CorMedix”) (NYSE Amex: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, today announced the...

May 3, 2012

NEW YORK--(BUSINESS WIRE)--Manhattan Research Releases New iPad Rep Report to Help Pharma Optimize Investments in 2012

May 3, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases, announced today the...

May 3, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus Inc. (NASDAQ: ZLCS) today reported financial results for the first quarter ended March 31, 2012. “We made tremendous progress advancing our pipeline this quarter and will continue this momentum with...

May 3, 2012

WASHINGTON--(BUSINESS WIRE)--cooperative agreement intended to help federal and private-sector employees improve efficiencies and reduce costs by expanding use of existing cyber-identities signed by leading identity trust hubs

May 3, 2012

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead to Present at Upcoming Scientific Conferences; Results Demonstrating Effectiveness of DPC siRNA Delivery System and Path to the Clinic for siRNA-based Hepatitis B Treatment

May 3, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen reported first quarter of 2012 earnings and strong bioprocessing business growth following December 2011 strategic acquisition.

May 3, 2012

BOULDER, Colo. & MILWAUKEE--(BUSINESS WIRE)--Covidien (NYSE: COV) and GE Healthcare (NYSE: GE), leading global providers of healthcare products and recognized innovators in patient monitoring and respiratory care devices, today announced a...

May 3, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced that data from several company-sponsored studies of naltrexone for extended-release injectable suspension (XR-NTX) are scheduled to be presented at the 2012 American Psychiatric...

May 3, 2012

WOBURN, Mass.--(BUSINESS WIRE)--ArQule reports first quarter fiscal year 2012 results.

May 3, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta (NASDAQ: SNTA) today provided a clinical program update and reported financial results for the quarter ended March 31, 2012. Company announces plans to proceed into Phase 3 by year-end.

May 3, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced top-line results of a randomized, controlled Phase 2 clinical trial of IMO-2055, the Company’s investigational oncology product candidate targeting Toll...

May 3, 2012

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced its financial results for the first quarter ended March 31, 2012. “AMPYRA continues to make unique and important contributions to the lives of people with...

May 3, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced a broad expansion of the cabozantinib development program under a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute...

May 3, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--Global Scientific Community Embraces New Parkinson’s Therapy

May 3, 2012

PARIS--(BUSINESS WIRE)--Biomedical Diagnostics (BMD) becomes Theradiag and moves into theranostics

May 3, 2012

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine (STO:AEROB): January – March 2012 Global Net sales grew by 76% to SEK 39.0m (22.2). Adjusted for currency fluctuations, net sales rose by 72% The worldwide number of NIOX MINO® repeat...

May 3, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Paris:IPN) (Euronext: IPN; ADR: IPSEY) reported today its sales for the first quarter 2012. First quarter 2012 unaudited IFRS consolidated sales   (in million euros)       2012       2011       %...

May 3, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the SUMMACTA study met its primary endpoint, showing comparable efficacy (non-inferiority) of the subcutaneous...

May 3, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme announced today that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved a second suite for filling and finishing product at its Waterford, Ireland m

May 3, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that its Board of Directors declared a second quarter dividend of $0.23 per common share. This dividend amount is equal to the...

May 2, 2012

MINNEAPOLIS & MELBOURNE, Australia--(BUSINESS WIRE)--Osprey Medical today announced that it has successfully listed on the ASX, under the ticker “OSP”. The stock has listed at a premium, gaining 5% in early trading on the ASX this morning. “...

May 2, 2012

MILWAUKEE--(BUSINESS WIRE)--Cynthia Dohmen LaConte named semin-finalist in E & Y's Entrepreneur of the Year Upper Midwest.

May 2, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE Amex: NAVB) Announces First Quarter 2012 Results: Business Update / Quarterly Conference Call Set for Tomorrow, May 3, 2012, at 8:30 am EDT

May 2, 2012

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec to Present at Deutsche Bank Conference

May 2, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) announced today that Frank Karbe, the company’s executive vice president and chief financial officer, will present at the upcoming Deutsche Bank Securities 37th Annual...

May 2, 2012

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB: FCSC), an autologous cellular therapeutic company focused on the development of innovative products for aesthetic, medical and scientific applications, announced today that David...

May 2, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River announces first-quarter 2012 results